Nuvo Research Inc. (NRI.TO) Announces European Launch of Pliaglis® by Galderma Pharma S.A.
4/23/2013 9:44:38 AM
More...
|
Galderma Pharma S.A., One of the Leading Pharmaceutical Companies, Relies on Verizon Enterprise Solutions to Provide Expanded, Secure Global Communications Platform
3/21/2013 10:37:24 AM
More...
|
Galderma Pharma S.A., World’s Leading Company Focused Exclusively on Dermatology, Acquires Spirig Pharma Ltd.
12/12/2012 9:29:04 AM
More...
|
Valeant Pharmaceuticals International (VRX) Signs Revised Deal With Galderma Pharma S.A.
12/6/2012 7:02:49 AM
More...
|
Nuvo Research Inc. (NRI.TO) and Galderma Pharma S.A. Announce FDA Approval of Pliaglis
10/22/2012 7:17:38 AM
More...
|
NovaBay Pharmaceuticals, Inc. Receives $2.6 Million From Partner Galderma Pharma S.A.
9/26/2012 9:20:29 AM
More...
|
Galderma Pharma S.A. and NovaBay Pharmaceuticals, Inc. Enroll First Patients in Phase 2b Clinical Study of NVC-422 for Impetigo
9/24/2012 9:48:53 AM
More...
|
Galderma Pharma S.A. Announces Positive US Pivotal Interim 6-Month Results for EMERVEL Classic Lidocaine Compared to Juvederm Ultra
10/20/2011 11:03:55 AM
More...
|
Galderma Pharma S.A. Announces Positive Phase 2b Results for Investigational Compound Targeting Redness of Rosacea
10/20/2011 7:13:10 AM
More...
|
Graceway Pharmaceuticals, LLC Reaches Agreement to Sell its Assets to Galderma Pharma S.A. for Undisclosed Amount
9/28/2011 8:37:28 AM
More...
|
|